Last updated on October 2018

A Long-Term Registry of Humira (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

Brief description of study

This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label.

Clinical Study Identifier: NCT01848561

Contact Investigators or Research Sites near you

Start Over


Premier Medical Group /ID# 140388
New Windsor, NY United States
  Connect »